gavin
Topics Engaged In
-
- Topic
- Voices
- Last Post
-
- Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary
- 1
- 3 years, 4 months ago
- Cholangiocarcinoma: shedding light on the most promising drugs in clinical devel
- 1
- 3 years, 4 months ago
- The Future of Health Care – Join Team Medicine at Virginia Mason Medical Center
- 1
- 3 years, 4 months ago
- Hepatobiliary Cancer Risk in Patients With Inflammatory Bowel Disease: A Scandin
- 1
- 3 years, 4 months ago
- Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic revi
- 1
- 3 years, 4 months ago
- Percutaneous biliary stent with intraluminal brachytherapy versus palliative sur
- 1
- 3 years, 4 months ago
- The efficacy and safety of apatinib treatment for patients with advanced or recu
- 1
- 3 years, 4 months ago
- Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage fai
- 1
- 3 years, 4 months ago
- Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant
- 1
- 3 years, 4 months ago
- Total upper transversal hepatectomy with outflow reconstruction for advanced mas
- 1
- 3 years, 4 months ago
- Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Pat
- 1
- 3 years, 4 months ago
- Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholan
- 1
- 3 years, 4 months ago